Related Experiment Video
Updated: May 12, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Chemotherapy-induced takotsubo cardiomyopathy
Sakima A Smith1, Alex J Auseon
1Division of Cardiovascular Medicine, Davis Heart & Lung Research Institute, The Ohio State University Medical Center, Suite 200, 473 West 12th Avenue, Columbus, OH 43210-1252, USA. sakima.smith@osumc.edu
Abstract:
Stress cardiomyopathy, also known as takotsubo cardiomyopathy, is a rapidly reversible form of acute heart failure classically triggered by stressful events. It is associated with a distinctive left ventricular contraction pattern described as apical akinesis/ballooning with hyperdynamic contraction of the basal segments in the absence of obstructive coronary artery disease. The traditional paradigm has expanded to include other causes, in particular chemotherapeutic drugs. The literature increasingly suggests an association between cancer, chemotherapeutic drugs, and stress cardiomyopathy. Chemotherapy-induced takotsubo cardiomyopathy is a relatively new phenomenon, but one that merits detailed attention to the elucidation of possible mechanistic links.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Myocarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care

